Tag - covid-19-vaccines

 
 

COVID 19 VACCINES

Japan Times
WORLD / Science & Health
Feb 21, 2023
COVID hasn’t taught the world how to beat the next deadly virus
Elimination measures were once the gold standard for dealing with deadly new viruses. But China’s extreme 'zero-COVID' policy and its abrupt reversal has cast doubts over the approach.
Japan Times
COMMENTARY / World
Jan 30, 2023
One-size-fits-all COVID-19 booster plan needs a rethink
Public health officials should recognize that additional COVID-19 booster shots should now be a more nuanced decision.
Japan Times
JAPAN / Explainer
Jan 29, 2023
What will change when Japan reclassifies COVID-19?
Japan is planning to downgrade the categorization of COVID-19 on May 8. How will that impact residents?
Japan Times
JAPAN
Jan 26, 2023
COVID-19 shots should remain free to residents, health ministry experts say
Prime Minister Fumio Kishida is expected to announce the decision to downgrade the classification of COVID-19 on Friday.
Japan Times
WORLD
Jan 26, 2023
Updated COVID-19 vaccines prevented illness from latest variants, CDC says
The analysis found that the updated vaccine helped prevent illness in people who had previously received two to four doses of the original COVID-19 vaccine.
Japan Times
WORLD / Science & Health
Jan 19, 2023
COVID immunity lasts at least a year after infection plus shots, study says
The combination prevented more than 97% of severe disease or hospitalization for up to 12 months after infection or initial immunization.
Japan Times
WORLD / Science & Health
Jan 14, 2023
Pfizer's bivalent vaccine linked to rare strokes in older people in preliminary U.S. data
The early finding still needs more investigation, and recommendations for the vaccine have not been changed, a statement by the U.S. Food and Drug Administration said.
Japan Times
BUSINESS
Jan 13, 2023
Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine
An approval would give Japan a homegrown mRNA vaccine — a vaccine type that has played a dominant role in the country's COVID-19 inoculation drive to this point.
Japan Times
COMMENTARY / World
Jan 11, 2023
Don't write off the retooled COVID-19 boosters
Two new studies claim the bivalent omicron shot is no better than the original vaccine. But there are important caveats.
Japan Times
WORLD / Science & Health
Jan 8, 2023
Health experts warily eye XBB.1.5, the latest omicron subvariant
The young version of the coronavirus could worsen what is already shaping up to be a rough COVID winter as people gather indoors and don't receive boosters that can ward off severe disease.
Japan Times
ASIA PACIFIC / FOCUS
Jan 7, 2023
The U.S. keeps offering China its COVID vaccines. China keeps saying no.
China has rebuffed repeated offers to share advanced vaccines as it battles a COVID-19 wave, a rejection that's frustrated American officials concerned about a resurgence of the pandemic.
Japan Times
COMMENTARY / World
Jan 6, 2023
No, vaccines aren’t making new COVID-19 variants worse
The omicron sequel XBB.1.5 is driving a new wave of COVID-19 infections — and misinformation.
Japan Times
ASIA PACIFIC
Dec 19, 2022
'I don't trust it:' Vaccine hesitancy lingers in China even as COVID cases surge
China's overall vaccination rate is above 90%, but the rate for boosted adults drops to 57.9%, and to 42.3% for people age 80 and above.
Japan Times
WORLD / Science & Health
Dec 17, 2022
New COVID booster shots cut hospitalization risk by half, CDC reports
The research represents the CDC's first look at how the bivalent boosters are performing in the prevention of severe consequences of infection with the virus.
Japan Times
ASIA PACIFIC
Dec 9, 2022
Challenging last mile for China's vaccine push after 'zero-COVID' retreat
Health risk analysis firm Airfinity has predicted as many as 2.1 million COVID-19 fatalities at current immunity levels.
Japan Times
WORLD / Science & Health
Nov 23, 2022
Bivalent COVID boosters give some protection in CDC study, but not much
Experts say it's still unclear whether the updated shots are any better than earlier versions at preventing hospitalization and severe illness.
Japan Times
COMMENTARY / World
Nov 21, 2022
Pfizer’s RSV vaccine succeeds where others failed
Early data bodes well for Pfizer's RSV shot, which would be given during pregnancy to protect infants in the early months of life.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?